| Mrs Gabriella L D'ambrosio, | |
|
911 Sunset Rd, Burlington, NJ 08016-2250 | |
| (609) 387-8787 | |
| (609) 386-8640 |
| Full Name | Mrs Gabriella L D'ambrosio |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 24 Years |
| Location | 911 Sunset Rd, Burlington, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023181252 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AM0700X | Physician Assistant - Medical | 25MP00059000 (New Jersey) | Primary |
| 208D00000X | General Practice | 25MP00059000 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advocare Llc | 3678562188 | 288 |
News Archive
Analysis from business intelligence provider GBI Research - Prostate Cancer Market to 2021 - Increasing Disease Prevalence to be a Key Driver of Market Growth - says that the prostate cancer market will expand at a rapid Compound Annual Growth Rate (CAGR) of 9.5% from $7.6 billion in 2014 to $13.6 billion by 2021.
Radical treatment such as surgery and radiation for localized prostate cancer may cause significant side effects. Active surveillance is increasingly accepted as an option for treating patients with clinically insignificant disease to maintain their quality of life.
Officials of Kylin Therapeutics Inc., a leading RNAi company, announced this week that they received an issued patent from the U.S. Patent and Trademark Office.
Research from The Shiley Center for Orthopaedic Research and Education at Scripps Clinic could change how patients are treated to prevent blood clots after joint replacement surgery. A study published as the lead article in the current issue of the Journal of Bone and Joint Surgery determined that after lower extremity joint replacement surgery a mobile compression device was just as effective as blood thinners in preventing deep vein thrombosis (DVT), but without negative side effects including bleeding complications.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Gabriella L D'ambrosio, 911 Sunset Rd, Burlington, NJ 08016-2250 Ph: (609) 387-8787 | Mrs Gabriella L D'ambrosio, 911 Sunset Rd, Burlington, NJ 08016-2250 Ph: (609) 387-8787 |
News Archive
Analysis from business intelligence provider GBI Research - Prostate Cancer Market to 2021 - Increasing Disease Prevalence to be a Key Driver of Market Growth - says that the prostate cancer market will expand at a rapid Compound Annual Growth Rate (CAGR) of 9.5% from $7.6 billion in 2014 to $13.6 billion by 2021.
Radical treatment such as surgery and radiation for localized prostate cancer may cause significant side effects. Active surveillance is increasingly accepted as an option for treating patients with clinically insignificant disease to maintain their quality of life.
Officials of Kylin Therapeutics Inc., a leading RNAi company, announced this week that they received an issued patent from the U.S. Patent and Trademark Office.
Research from The Shiley Center for Orthopaedic Research and Education at Scripps Clinic could change how patients are treated to prevent blood clots after joint replacement surgery. A study published as the lead article in the current issue of the Journal of Bone and Joint Surgery determined that after lower extremity joint replacement surgery a mobile compression device was just as effective as blood thinners in preventing deep vein thrombosis (DVT), but without negative side effects including bleeding complications.
› Verified 6 days ago